AmerisourceBergen Sees Momentum Build In US Biosimilars

Key Developments Around Insulins And Interchangeability Slated For 2021

 
• By David Wallace
Amerisource_Bergen
AmerisourceBergen sets out its vision for US biosimilars in 2021 • Source: Shutterstock

More from Biosimilars

More from Products